HomeIndustriesTechnologyNvidia (NVDA) To Launch Chips For Chinese Market & Eli Lilly (LLY) Gains Weight Loss Drug Approval

Nvidia (NVDA) To Launch Chips For Chinese Market & Eli Lilly (LLY) Gains Weight Loss Drug Approval

Nvidia (NVDA) is to launch three chips for the Chinese market. NVDA stock is up 225% year-to-date. According to Reuters, NVDA’s chips for the Chinese market are expected to be announced as early as next week. These chips come after Baidu ordered chips from Huawei instead of NVDA. Kevin Green discusses this, along with how Eli Lilly (LLY) gains FDA approval for a weight loss drug, Zepbound. Zepbound helped people lose 52 pounds in 16 months in clinical trials. Tune in to find out more about the stock market today.

Trading 360

09 Nov 2023

SHARE

ON AIR
12:00 pm
Next Gen Investing
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
7:00 am
Morning Movers
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
ON AIR
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
7:00 pm
Market Overtime
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Market Overtime
REPLAY
9:30 pm
Market Overtime
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor